CONFERENCE OVERVIEW

Tuck's first annual healthcare conference examines the impact of globalization on the pharmaceutical and biotechnology ("biopharma") industries. Biopharma companies increasingly are searching the world both for new markets and for opportunities to reduce drug development costs. The conference will address questions of how globalization is changing the pricing and sourcing decisions of biopharma companies and the structure of the companies themselves.

In the race to develop new drugs, do global companies have a competitive edge? How can companies take advantage of emerging countries to reduce drug development costs? Is the industry headed for a truly global model of development and production? What unique barriers might they face in attempting to offshore product development and what are the prospects for this type of activity in the future?

Biopharma companies operate in a world where payment systems can vary dramatically by country. Is this situation sustainable in the face of increased integration among economies and societies across the globe? How might payment systems change over time?

Keynote Address
Peter R. Dolan T'80
Former Chairman & CEO, Bristol-Myers Squibb
"The Effects of Globalization on the Biopharma Industry"

PLEASE NOTE:

Due to overwhelming demand, conference registration is now closed. We thank you for your interest, and apologize for any inconvenience.

The conference panels beginning at 1:30PM have been moved to the Cook Auditorium, Murdough Center, Tuck School. Please refer to the Directions tab, above, and signs at the venue.

The location of the keynote luncheon remains the same - Cohen Great Hall, Whittemore Building, Tuck School.